A post-marketing surveillance study for Repatha Inj. (evolocumab) in Korea text (20160156)

25/07/2017
05/06/2024
EU PAS number:
EUPAS19680
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Repatha PMS_20160156_ver 1 redacted

English (670.63 KB - PDF) View document
Study results
Study results

20160156 ORSR_Redacted

English (171.48 KB - PDF) View document
Study report
Other information